Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Why Johnson & Johnson Stock Is Not a Screaming Buy

By Thomas Niel, InvestorPlace Contributor

For dividend investors looking for a high-quality name, Johnson & Johnson stock may be a solid opportunity. For investors looking for a stock to rebound, better opportunities lie elsewhere.

Amazon Stock is a ‘Prime’ Opportunity — At a Lower Price

By Thomas Niel, InvestorPlace Contributor

Expansion of brick-and-mortar, along with new technologies, could sustain growth for Amazon stock. But wait for a pullback to buy shares.

Down 20% in a Month, Shopify Stock Isn’t Worth Buying Yet

By Thomas Niel, InvestorPlace Contributor

Shopify stock could bounce back if its move to fulfillment services works. But investors should stay away due to the high valuation of SHOP.

Pretty Much Any Pot Play Makes More Sense Than Buying Tilray Stock

By Thomas Niel, InvestorPlace Contributor

The company has several catalysts in play, but nothing unique compared to what other cannabis companies are doing. I remain on the fence with pot stocks in general. But if I were entering a position today, I would choose something like Hexo or Aphria to place my bet on the legalized marijuana story. I suggest you do the same. Look elsewhere for a pot play, but steer clear of TLRY stock.

Hexo Stock Is Cheap on a Forward Basis—but Success Is Not Guaranteed

By Thomas Niel, InvestorPlace Contributor

I remain on the fence with pot stocks, and Hexo is no exception. But if we finally get the anticipated market correction, the stock could be a buy. Keep it on your radar, and pounce if the Hexo stock price falls to a lower valuation.

Load More